Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-03-19
1991-10-22
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548166, C07D27780, A61K 31125
Patent
active
050596136
ABSTRACT:
This invention is directed to compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof wherein R.sub.6 is hydrogen or lower alkyl;
REFERENCES:
patent: 3323999 (1967-06-01), Nechay et al.
patent: 4386098 (1983-05-01), Woltersdorf, Jr. et al.
patent: 4416890 (1983-11-01), Woltersdorf, Jr.
patent: 4424227 (1984-01-01), Robert
patent: 4426388 (1984-01-01), Woltersdorf, Jr.
patent: 4454148 (1984-06-01), Woltersdorf, Jr. et al.
patent: 4456599 (1984-06-01), Woltersdorf, Jr.
patent: 4470991 (1984-09-01), Woltersdorf, Jr.
patent: 4472417 (1984-09-01), Woltersdorf, Jr.
patent: 4472418 (1984-09-01), Woltersdorf, Jr.
patent: 4483864 (1984-11-01), Barfknecht et al.
patent: 4483872 (1984-11-01), Barfknecht et al.
patent: 4500538 (1985-02-01), Woltersdorf
patent: 4505923 (1985-03-01), Hoffman
patent: 4510155 (1985-04-01), Smith et al.
patent: 4619939 (1986-10-01), Maren
patent: 4629738 (1986-12-01), Barfknecht et al.
patent: 4636515 (1987-01-01), Barfknecht et al.
Schoenwald et al., J. Med. Chem., 1984, 27: 810-812.
Ponticello et al., J. Med. Chem., 1987, 30: 591-597.
Maren et al., The Journal of Pharmacology and Experimental Therapeutics, 1987, 241: 56-63.
Maren, Drug Development Research, 1987, 10: 255-276.
Maren et al., Exp. Eye Res., 1983, 36: 457-480.
Maren et al., Current Eye Research, 1985, 4: 399-408.
Pierce, Jr. et al., Research Communications in Chemical Pathology and Pharmacology, 1985, 50: 3-20.
Eller et al., Journel of Pharmaceutical Sciences, 1985, 74:5; 525-529.
Gerstl Robert
Research Corporation Technologies Inc.
LandOfFree
Topically active ocular benzothiazole sulfonamide carbonic anhyd does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topically active ocular benzothiazole sulfonamide carbonic anhyd, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topically active ocular benzothiazole sulfonamide carbonic anhyd will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-108793